Page 53 - Markets Sensex Nifty

Pharma stocks advance; Ipca Labs, Cadila Healthcare soar up to 19%

Given India is relatively better placed to scale up and due to lower outbreak of Covid-19, India may benefit by supplying more to US and EU, analysts say.

Coronavirus pandemic burns Rs 1.9 trillion hole in LIC's investments

The value of insurer's holdings in listed companies at the end of December 2019 quarter stood at Rs 6.02 trillion

India's economic policy response to Covid-19 lags global peers: Edelweiss

"We think Indian policymakers must catch up and that too in a short time," analysts at the brokerage firm wrote.

No point in banning short sale or stock exchange shutdown

The economic fallout of Covid-19 is yet to be analysed but it will have a significant impact on India Inc's earnings in the March quarter as well as in financial year 2020-21 (FY21).

Nifty Auto hits 6-year low; Maruti tumbles 11%, Ashok Leyland plunges 19%

Post the coronavirus outbreak, the correction in the auto index is now closer to that witnessed during the 2008 Global Financial Crisis (GFC) period, said HDFC Securities

L&T, KEC Int'l: Oil price crash, Covid-19 to hit capital goods companies

The sharp slide in crude oil prices of more than 40 per cent to $30/barrel is expected to impact overall orders/awarding from the Middle East and North Africa (MENA) region

YES Bank soars 96% in 2 days on Moody's ratings upgrade, positive outlook

The global rating agency Moody's has upgraded YES Bank's long-term foreign currency rating from "Caa3" to "Caa1" on bail-out package

India Cements jumps over 8% as Damani family increases stake in Co to 16%

So far in the calendar year 2020, shares of The India Cements have outperformed the market by surging over 34 per cent

Market valuation is attractive; time to take risk for long-term gains

The current problem that looks to be temporary, isn't changing the longer-term structural economic growth opportunity.

Nifty outlook and top stock picks by CapitalVia: Buy Indian Oil Corp, HPCL

As per weekly option data, handful of call unwinding on higher strikes ranging from 10,000 to 10,300 can be seen which shows Nifty is losing its resistance in sub 10,200 zone.

Time to be greedy or fearful? Portfolio strategies for uncertain times

If you buy a high-quality business that has growth potential, then do not bother about short-term stock price fluctuations. These stocks will eventually rise as and when the tide turns.

What kind of bear market is this?

Are the markets overreacting? On Friday, the Indian markets were locked in the lower circuit on opening and leading to a mandatory halt in trading for 45 minutes

Markets are attractive after recent correction, says Neelesh Surana

Given the attractive valuations, we would recommend investors should capitalise on the same.

Tata Steel, ONGC: Stocks that have suffered the most in the market meltdown

While the Indian equities were isolated from the global rout till early February, the downfall began when the virus began to spread outside mainland China, its originating country.

Good time to start SIP in this market mayhem

The entire panic has been initiated by fears that the system to curtail the Coronavirus (COVID-19), across the globe, is misplaced.

Select pharma shares in focus, Nifty Pharma rebounds 16% from day's low

Aurobindo Pharma moved higher by 20 per cent to Rs 449, and witnessed 32 per cent rally in the intra-day deal.

Nifty hits lower circuit amid global sell-off; trading halted for 45 mins

Circuit Breaker is the mechanism which is triggered when the price fluctuation moves beyond a threshold value stipulated by the stock exchange.

Don't stay on the sidelines; time to buy stocks as per risk appetite

As regards coronavirus, it is very difficult to give a timeline as when things will recover.

Nifty can hit 9,200 mark if selling intensifies; 33,400 crucial for Sensex

For Nifty, a continuous gap-down sessions have dampened the upward move

A new bull-market will be born later this year: Goldman Sachs

A stock or index is said to be in a bear phase if the benchmark extends its decline to 20 per cent.